151 related articles for article (PubMed ID: 20532438)
1. Reduced blood pressure variability in ASCOT-BPLA trial favours use of amlodipine/perindopril combination to reduce stroke risk.
Aalbers J
Cardiovasc J Afr; 2010; 21(2):115. PubMed ID: 20532438
[TBL] [Abstract][Full Text] [Related]
2. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke.
Rothwell PM; Howard SC; Dolan E; O'Brien E; Dobson JE; Dahlöf B; Poulter NR; Sever PS;
Lancet Neurol; 2010 May; 9(5):469-80. PubMed ID: 20227347
[TBL] [Abstract][Full Text] [Related]
3. ASCOT blood pressure-lowering arm--study of effects of two BP-lowering regimens in hypertensive patients with cardiovascular risk factors.
Cardiovasc J S Afr; 2005; 16(2):124, 126-7. PubMed ID: 15915281
[No Abstract] [Full Text] [Related]
4. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
Dahlöf B; Sever PS; Poulter NR; Wedel H; Beevers DG; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J;
Lancet; 2005 Sep 10-16; 366(9489):895-906. PubMed ID: 16154016
[TBL] [Abstract][Full Text] [Related]
5. Impact of Statin Therapy on the Blood Pressure-Lowering Efficacy of a Single-Pill Perindopril/Amlodipine Combination in Hypertensive Patients with Hypercholesterolemia.
Sirenko Y; Radchenko G;
High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):85-93. PubMed ID: 28150140
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
Ruilope LM; Schaefer A
Contemp Clin Trials; 2011 Sep; 32(5):710-6. PubMed ID: 21586342
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Fixed-Dose Perindopril/Amlodipine on Clinic, Ambulatory and Self-Monitored Blood Pressure and Blood Pressure Variability: An Open-Label, Non Comparative Study in the General Practice.
Karpov YA; Gorbunov VM; Deev AD
High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):417-25. PubMed ID: 26351011
[TBL] [Abstract][Full Text] [Related]
8. [Optimization of BP Control and Arterial Elasticity With Fixed Combination Therapy Perindopril and Amlodipine In Patients With Arterial Hypertension and Increased Pulse Wave Velocity].
Nedogoda SV; Konradi AO; Zvartau NE; Chumachek EV; Ledyaeva AA; Tsoma VV; Salasyuk AS; Judina JS; Smirnova VO; Khripaeva VJ; Palashkin RV
Kardiologiia; 2017 Mar; 57(3):31-38. PubMed ID: 28762933
[TBL] [Abstract][Full Text] [Related]
9. Results of the ASCOT-BPLA trial: no practical implications for treatment of hypertension.
Prescrire Int; 2006 Jun; 15(83):112. PubMed ID: 16764103
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety Assessment of Hypertension Management with Coveram (Perindopril/Amlodipine Fixed Combination) in Patients with Previous Angiotensin Receptor Blocker (ARB) Treatment: Arabian Gulf STRONG Study.
Ahmed M; Alanbaei M; El Tamimi H; Al-Wahshi Y; Al-Zakwani I
Curr Vasc Pharmacol; 2016; 14(6):570-575. PubMed ID: 27456109
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.
Redon J; Pichler G;
J Hypertens; 2016 Feb; 34(2):359-67. PubMed ID: 26867060
[TBL] [Abstract][Full Text] [Related]
12. A new dimension in hypertension management with the amlodipine/perindopril combination.
Poulter NR
J Hypertens; 2011 Dec; 29 Suppl 1():S15-21. PubMed ID: 22157563
[TBL] [Abstract][Full Text] [Related]
13. A review of Perindopril in the reduction of cardiovascular events.
Campbell DJ
Vasc Health Risk Manag; 2006; 2(2):117-24. PubMed ID: 17319455
[TBL] [Abstract][Full Text] [Related]
14. Which patients benefit the most from the perindopril/amlodipine combination.
Mourad JJ
J Hypertens; 2011 Dec; 29 Suppl 1():S23-8. PubMed ID: 22157564
[TBL] [Abstract][Full Text] [Related]
15. The ASCOT trial: clarifying the role of ACE inhibition in the reduction of cardiovascular events in patients with hypertension.
Meurin P
Am J Cardiovasc Drugs; 2006; 6(5):327-34. PubMed ID: 17083267
[TBL] [Abstract][Full Text] [Related]
16. Treatment with Free Triple Combination Therapy of Atorvastatin, Perindopril, Amlodipine in Hypertensive Patients: A Real-World Population Study in Italy.
Perrone V; Veronesi C; Gambera M; Nati G; Perone F; Tagliabue PF; Degli Esposti L; Volpe M
High Blood Press Cardiovasc Prev; 2019 Oct; 26(5):399-404. PubMed ID: 31463886
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy in the extended cardiovascular continuum: a focus on perindopril and amlodipine.
Borghi C; Morbini M; Cicero AF
J Cardiovasc Med (Hagerstown); 2015 May; 16(5):390-9. PubMed ID: 25590639
[TBL] [Abstract][Full Text] [Related]
18. Perindopril/amlodipine (Prestalia(®)): a review in hypertension.
Shirley M; McCormack PL
Am J Cardiovasc Drugs; 2015 Oct; 15(5):363-70. PubMed ID: 26341621
[TBL] [Abstract][Full Text] [Related]
19. Optimization of blood pressure treatment with fixed-combination perindopril/amlodipine in patients with arterial hypertension.
Hatala R; Pella D; Hatalová K; Šidlo R
Clin Drug Investig; 2012 Sep; 32(9):603-12. PubMed ID: 22877321
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.
Bath P
Stroke; 2003 May; 34(5):1334-5. PubMed ID: 12702833
[No Abstract] [Full Text] [Related]
[Next] [New Search]
